The following delegates have already registered to attend OIS@AAO.  Sign up today to be added to this growing list!


Ace Vision Group
Bradley Hall, Director, Clinical Research & Education
AnnMarie Hipsley, MD, Founder & CEO
Bruce Kaufaman, Consultant/Advisor
Donald Robinson, VP, Business Development

Achillion Pharmaceuticals
Anthony Gibney, EVP, Chief Business Officer
Daniel Kennedy, Executive Director, Business Development
Ben Plaster, Director, Product Management
Steven Zelenkofske, MD, EVP, Chief Medical Officer

Jeff Gregory, MD, MBA, VP of Clinical Development and Medical Affairs
Jim Niebanck, Chief Commercial Officer
John Shishilla, SVP, Retinal Health Monitoring

Magda Michna, PhD, Chief Global Clinical & Regulatory Affairs Officer
Yari Mitchell, Chief Business Development Officer
Sandy Selvaaggi, VP, Manufacturing & Quality Operations

Advanced Vision Institute
Eric Brooker, OD, FAAO, CEO

Adverum Biotechnologies
Sandipan Bagchi, Executive Director, Business Development
Diana Cepeda, Director, Novel Vector Technology
Mehdi Gasmi, President & Chief Scientific Officer
Claire Gelfman, VP, Pharmaceutical Development
Carol Hoang-Roller, VP, Medical Affairs
Aaron Osborne, Chief Medical Officer
Adam Turpcu, Director, Clinical Sciences
Jason Wang, Senior Manager, Corporate Strategy & Investor Relations

Aerie Pharmaceuticals
Vince Anido, PhD, Chairman & CEO
Ami Bavishi, Investor Relations
Jerry Cagle, PhD, Board Member
Gianluca Corbinelli, Chief Commercial Officer, Europe
Nancy Davis, Director, Global Clinical Operations
Mitchell deLong, PhD, VP, Chemistry
Ioana Grobeiu, Director, Medical Affairs, Europe
Tad Heitmann, MBA, Director, Corporate Communications
Evan Hockman, Product Director
Casey Kopczynski, PhD, Chief Scientific Officer
Richard Lewis, MD, Chief Medical Officer
Norbert Lowe, Regional Sales Director, West
Mike Mccleerey, VP, Portfolio Development
Kathy Mcginley, VP, Human Resources & Corp. Services
Kayley McKee, PhD, Director, Clinical Research
Deanne Melloy, VP, Marketing
Gary Menichini, VP, Sales
Tom Mitro, COO & President
Chong Nien, Manager, Clinical Science
Melissa Parker, Product Director
Jami Rogers, Product Manager, Rhopressa
Richard Rubino, CFO
Dale Seibt, VP, Market Access
Huan Sheng, MD, PhD, Director, Clinical Research & Drug Safety
Craig Skenes, VP, Business Development
Luis Vargas, Medical Director
Julie Whitcomb, Medical Science Liaison

Aerpio Pharmaceuticals
Joseph Gardner, PhD, President & Founder
Stephen Hoffman, PhD, MD, CEO
Kevin Peters, MD, CSO, CMO and SVP R&D

AffaMed Therapeutics
MaryJane Rafii, PhD, MBA, Senior Vice President

Theresa Heah, MD, Chief Medical Officer
Sue Washer, President & CEO

Regina Assaf, Director, Portfolio & Stakeholder Strategy
Ron Bruns, Executive Director, Branded Ophthalmics
Brett Novak, SVP Commercial Operations

Albert Einstein COM-Montefiore Med Ctr
Roy Chuck, MD, PhD, Chairman
David Rubaltelli, MD, MBA, Assistant Professor

Stephanie Ainscow, PhD, Global Head, Commercial Solutions
Sebastien Allard, Director, Corporate Development Strategy
Laurent Attias, SVP, Corporate Development Strategy, BD&L and M&A
Gordon Bethwaite, Director, Market Development, Dry Eye Devices
Charlotte Bonfield, Global Head, Executive Talent
Mike Cecil, Global Product Director, OH Innovation
Barry Cheskin, VP, Accommodating IOLs, Surgical R&D
Costin Curatu, PhD, Head, Search & Evaluation - Surgical, Business Development & Licensing
Sundeep Dutta, Global Product Director, Presbyopia Correcting IOLs
Brant Gillen, Global Product Director, Digital Health Solutions
Mark Gordon, SVP, Global Head Regulatory Affairs
Paul Hallen, Global Head, Surgical Vitreoretinal & Glaucoma
Julie Haynes, Associate Director, External Alliances Ops
Alan Landers, OD, MS, Head, Search & Evaluation Vision Care
Kendra Lohrmeyer, BD&L Operations Lead
Stephane Lucchini, Head, Search and Evaluation
Carla Mack, Global Head, Professional Affairs
Patrick Matthews, Head, BD&L Transactions
Kent McCarty, Business Development & Licensing
Vidhya Mellarkod, PhD, Head, Strategy USVC
Andy Pawson, President & GM, Global Vision Care
David Schwartz, Global Product Director Strategic Innovation
Matt Snakenberg, Head, Global BD&L and M&A
Shannon Spock, MPH, Head, Search & Evaluation
Jay Stark, Global Head, Surgical Visualization
Adam Szaronos, Head, Dry Eye Devices
Ahmet Tezel, PhD, VP, Surgical Franchise Head, R&D
Burton Tripathi, PhD, General Manager - TrueVision
Jason Watts, BD&L Senior Associate
Stephanie Waugh, Global Head, Ocular Health
Jason Weems, Head, Global BD&L Vision Care

Cassie Ysaguirre, Senior Legal Counsel

Aldeyra Therapeutics
Todd Brady, CEO
David Mcmullin, Chief Commercial Officer
Christopher Pearson, VP, Commercial

Alimera Sciences
Philip Ashman, PhD, Managing Director EMEA
Rick Eiswirth, President & CEO
Dan Myers, Chairman

All Eyes Consulting
Namrata Saroj, OD, Principal

Allegro Ophthalmics
Laurens Bouckaert, Marketing Consultant
Scott Cooper, CFO
Vicken Karageozian, MD, President & CEO

Marina Bejanian, Executive Director
Andrei Cervoneascii, Director, BD&L Commercial Assessments
Glen Curran, VP, Anterior Segment
Jag Dosanjh, SVP, US Eye Care
Doug Faunce, PhD, Executive Director, External Science & Innovation
Margot Goodkin, Executive Director, Clinical Development
Yehia Hashad, MD, Senior Vice President
Chuck Holmes, Associate VP, International Head of Eye Care
David LeCause, VP, Eye Care
Charles Liu, Executive Director, Device R/D
Francisco Lopez, Executive Director, Clinical Development
Sesha Neervannan, PhD, SVP, R&D Pharmaceutical Development
C David Nicholson, PhD, Chief R&D Officer
Jai Parekh, MD, MBA, FAAO, Chief Medical Officer & VP
David Pyott, MD, Former Chairman & CEO
Michael Robinson, MD, VP, Therapeutic Area Head, Ophthalmology
Baldo Scassellati Sforzolini, Senior Vice President
Michelle Senchyna, PhD, Executive Director, Clinical Development, Eye Care
Chuck Silberstein, MD, Senior Vice President
Julian Smith, Executive Director, US Portfolio Expansion
Andrew Stewart, Associate VP, US Commercial Eye Care
Ramin Valian, VP, Marketing, Interventional Glaucoma, Reimbursement & Pipeline
Dawn Gaydos, Associate VP of Specialty Eye Care

Michael Mrochen, President

David Muller, CEO

Allysta Pharmaceuticals
Henry Hsu, MD, CEO

Alpine Biotherapeutics
Keith Bryant, Chief Business Officer

Altacor Limited
Charlotte Phelps, CEO

American Academy of Ophthalmology
Jane Aguirre, VP, Membership & Alliances
Dale Fajardo, EdD, MBA, VP, Education
Keng Jin Lee, PhD, Managing Editor
Flora Lum, MD, VP, Quality & Data Science
Todd Lyckberg, Director, Development

Amring Pharmaceuticals
Erika Geimonen, PhD, VP, Business Development

Annexon Biosciences
Douglas Love, CEO
Ted Yednock, PhD, Chief Scientific Officer

APEC Hospital
Everardo Hernandez Quintela, MD, Director of Research

Hugo Quiroz-Mercado, MD, Chairman Translational Research

Apellis Pharmaceuticals
Tim Antonellis, Senior Clinical Trial Manager - Ophthalmology
Victoria Brown, VP - Head of Global Commercial Strategy
Michael Dovey, Director - Global Business Intelligence
Cedric Francois, CEO
Federico Grossi, Chief Medical Officer - Clinical
Robb Lawrence, Chief Business Officer
Ramiro Ribeiro, Medical Director
Namrata Saroj, Medical Science Liaison
Lukas Scheibler, PhD, CIO

Aptitude Medical Systems
Scott Ferguson, PhD, CEO
Qiang Gong, Founder & COO

Cariad Chester, Principal

Arix Bioscience Investments
Mark Chin, Investment Director

AsclepiX Therapeutics
Wendy Perrow, MBA, CEO
Niranjan Pandey, PhD, VP, Head, R&D
Kevin Slawin, MD, Board of Directors

ASICO / P.S.Therapy
Ravi Nallakrishnan, Managing Director

Astellas Pharma
Mina Kikuchi, PhD, Director, Global Development Project Leader
Mari Nakabayashi, PhD, Medical Director
Masanori Yokono, PhD, Associate Director

Salvador Carlucci, Director

Atia Vision
Tracy Valorie, Business Advisor

Aura Biosciences
Elisabet de los Pinos, CEO, PhD
Julie Feder, CFO
Cadmus Rich, MD, Chief Medical Officer

Rajesh Rajpal, MD, Chief Medical Officer
Jim Schuermann, Chief Business Officer
Reza Zadno, PhD, President & CEO

Avellino Labs
Eric Bernabei, Chief Sales & Marketing Officer
Thomas Kim, Chief Strategy Officer & Corporate Secretary
Lynn Kim, Chief, Staff
Gene Lee, Chairman & Founder
Benedetto Sgroi, VP, International Marketing & Sales

Aviceda Therapeutics
Mohamed Genead, MD President, CEO & Co-Founder

Achim Krauss, PhD, President & CEO

Azura Ophthalmics
Yair Alster, MD, Chief Technology Officer
Hila Barash, VP, Research & Development
Charles Bosworth, Chief Medical Officer
Marc Gleeson, CEO


Bascom Palmer Eye Institute
Richard Awdeh, MD, CEO
Kendall Donaldson, MD, Professor of Ophthalmology
Terrence O'Brien, MD, Director, the Refractive Surgery Service

Bausch + Lomb
Yolande Barnard, VP & General Manager
Luc Bonnefoy, VP Surgical International
Ernie Bravo, Director, Marketing
David Fisher, VP, Marketing
Rajeev Garg, Executive Director, Surgical Marketing
Joseph Gordon, President
Charles Hess, VP & General Manager, US Surgical
Robert Kissling, MD, VP, Medical Affairs
Brent Lindsey, National Sales Director
Calvin Roberts, MD, SVP, Chief Medical Officer, Eye Heath

Bausch Health
Sandeep Lalit, VP, Business Development

Bay Area Retina Associates
Tushar Ranchod, MD, Founder, Chief Technical Officer

Rafiq Hasan, MD, Global Head, Ophthalmology
Yen Hsu, Deputy Director
Shek Wei Teoh, Global Marketing Director, Ophthalmology

Baylor College of Medicine
Jack Holladay, MD, Clinical Professor, Ophthalmology

Beaver Visitec International
Darin Dixon, VP, Sales

Belite Bio
Irene Wang, COO

Barry Butler, CEO

Beyeonics Surgical
Ron Schneider, CEO

Beyond 700 P/L
Ross Harricks, Director

Anne Joseph, PhD, Manager S&E
Zoe Klein, PhD, Manager, Business Development
Tuyen Ong, MD, MBA, Ophthalmology Franchise Head
Nick Scarchilli, Director, Business Development

Jeffrey Gross, MD, Managing Partner & Co-Founder

Bionic Vision Technologies
Ash Attia, CEO
Brian Gordon

BioQuest, A Diversified Search Company
Roger Anderson, Managing Director
Kim Ennis, Managing Director
Dave Mildrew, Managing Director
Peter Schineller, Managing Director

Bios Partners
Stella M. Robertson, PhD, Co-Founder

Biovisics Medical
Paul Rockley, CCO

Blackstone Life Sciences
Emmett Cunningham, Jr., MD, PhD, MPH, Senior Managing Director

Bluestem Capital
Drew Doshier, Investment Associate
Jon Kirby, Senior Associate, Investor Relations
Tyler Stowater, Partner

Stephen Daily, Executive Editor, News
Ranna Jaraha, Director, New Media

Boehringer Ingelheim International GmBH
Victor Chong, MD, Global Head of Medicine, Retinal Health
Andrea Giani, MD, Senior Clinical Program Leader

Michael Waggoner

Boston Children's Hospital
Daniel Kohane, MD, PhD, Professor, Anesthesia

Barrett Katz, MD, President & Chief Medical Officer
Sandy Mong, MD, VP, Business Development & Operations
Glenn Noronha, PhD, Chief Scientific Officer

BSM Consulting
Laurie Brown, MBA, COE, COMT, CPC, CPMA, Senior Consultant

Ryan Zimmerman, Director, Equity Research Medical Technology

Lars Bonefeld, VP, Global Marketing
Lindsay Ladenburg, District Manager


Frances Lasowski, PhD, Executive Director
Heather Sheardown, Scientific Director

Cadient, A Cognizant Company
Erica Metzger, Social Strategist

California Pacific Medical Center
Rona Silkiss, MD, Chief, Division of Ophthalmic Plastic, Reconstructive & Orbital Surgery

Cambridge Consultants
Luis Diaz-Santana

Carl Zeiss Meditec
Mikhail Boukhny, PhD, Head, R&D Surgical Ophthalmology
Wayne Caulder, Head, US Sales, OPT & MCS
Andrew Chang, Head, Global Sales, Ophthalmic Devices
Laurie Ferguson, Head, OPT Global Communications
Dr. Michael Kaschke, President, CEO & Labor Director
Aaron Kim, General Counsel
Amelie Koch, Head, Global Strategy
Jim Mazzo, Global President, Ophthalmic Devices
Scott Meyer, Director, Strategic Business Development
Dirk Muehlhoff, VP, Refractive Laser Business Unit
Erin Powers, VP, Medical Affairs & Professional Education
Angelo Rago, Global Head, Ophthalmic Diagnostics
Karlheinz Rein, SVP & Head, Business Sector Surgical Ophthalmology
Steve Schallhorn, MD, Chief Medical Officer
Alice Swinton, Head of Content Management
Brian Walsh, General Manager
Justus Wehmer, CFO

Casey Eye Institute - OHSU
Mark Pennesi, MD, PhD, Associate Professor

Catalyst Biosciences
Grant Blouse, PhD, VP, Translational Research
Jeff Landau, VP, Business Development

Cativer Bio Insights
Stephen Judd, President

Mike Garanzini, CEO

CB Vision
Charlotte Butler, R&D Consultant

CBC Group
H. Michael Keyoung, MD, PhD, Managing Director & Head, North America

C-Bridge Capital
Tong Zhang, Managing Director

Veronique Jotterand, MD, Co-Founder
Michelle Tarver, MD, PhD, Medical Officer

Cell Care Therapeutics
Nicolas Sohl, CEO

Cellview Imaging
Rishard Weitz, CEO

Center For Excellence In Eye Care
William Trattler, MD, President

Center for Sight
Eva Liang, MD, Medical Director

Central Valley Eye Medical Group
Kimberly Cockerham, MD, FACS, Adjunct Clinical Associate Professor, Stanford Department of Ophthalmology

Centro De Investigacion Sophia Sa De CV
Alejandro Espinosa Lopez, LIC, Strategic Business Manager

John Cullity, MD, Director

Keay Nakae, Senior Healthcare Research Analyst

Charles Retina Institute
Steve Charles, MD, Founder & Chairman

Jim Decker, Senior Vice President
Lindsay Licata, VP Sponsorship Sales
Ciro Maria, VP Sponsorship Sales
Bob Mons, VP Sponsorship Sales
Marijo Montgomery, VP, Sponsorship Sales

Chengdu Kanghong Pharmaceutical Group
Yi Li, Account Manager
Li Liu, PhD, Associate Director, Corporate Development
Fang Zhang, Corporate Development Manager

Joshua Parks, Founder

CHU Clermont Ferrand
Hayette Rebika, MD, Ophthalmologist

Clarion Healthcare
Carol Kearney, Managing Director

Claris Bio
Anton Atwell, President & CEO

Clearside Biomedical
Charlie Deignan, CFO
Rick McElheny, VP, Corporate Development

ClearView Healthcare Partners
Debbie Zhuang, Managing Director

Cleveland Clinic
Arjun Sood, Vitreoretinal Surgery Fellow

Cleveland Research Company
Steve Willoughby, Senior Research Analyst

Bill Van Nostrand, Head of Global Alliances

Hayley Lane, Consultant

Clinreg Consulting Services
Debe Deck, Regulatory Consultant
Judy Gordon, DVM, Regulatory Consultant
Maureen Johnson, RN, Regulatory Consultant
Lee Kram, MD, MSE, Regulatory Consultant

Coherus Biosciences
Rajat Agrawal, SVP, Clinical Development - Ophthalmology

Columbia University
Jeffrey Liebmann, MD
Stephen Trokel, Professor

Compact Imaging
Don Bogue, CEO

Consulting and Marketing
Joel Gaslin, EVP, Sales & Marketing

Contract Lasik Provider
James Rynerson, MD, CEO

Paul Chamberlain, Director, Research Programs, R&D
Nancy Keir, Senior Director, Program & Biological Sciences, R&D
Percy Lazon, PhD, Director
John McNally, Senior Director, Clinical Research, R&D

John Guckes, Senior Advisor
Howard Mendelsohn, CFO
Monty Montoya, President & CEO
Bob Stevens, CTO
James Wachtman, CCO
Jim Wachtman, Chief Commercial Officer

Chris Moore, President


Deerfield Management
Andrew ElBardissi, Investor

Dalton & Associates
Michelle Dalton, Founder & President

Department of Ophthalmology, Gachon University Gil Medical Center, Incheon, Korea
Dong Heun Nam, MD, PhD, Professor

Diabetes Eye
Anil Goyal, MD, Physician

Brian Baum, Vice President
Stephen Cary, Vice President
Ashley Kline, General Manager
Georgea Pasedis, PharmD, Head, Medical Affairs

Drusolv Therapeutics
John Edwards, CEO

Dry Eye and Cornea Treatment Center
Steven Maskin, MD, Founder and Inventor

Duke University Eye Center
Carolina Betancurt, OD, MBA, Director Center for Ocular Immunology

Durrie Vision
Daniel Durrie, MD, Founder & Physician


East West Eye Institute
James Masunaga, CFO

El Camino Hospital Los Gatos
Gloria Wu, MD, Gloria Wu, MD PC, President

Eloxx Pharmaceuticals
Doug McMillin, Director, Alliance Management
Susan Schneider, MD, SVP Clinical Development, Ophthalmolgy
David Snow, Chief Business Officer

Noelia Kunzevitzky, PhD, COO

Encompass Pharmaceutical Services
Richard Coulon, Head of Marketing and Sales
Thomas Rowe, President

Equinox Ophthalmic
Gary Berman, Chief Business Officer
Chris Hafner, Director, Clinical & Regulatory Affairs
Matt Larson, President & COO
Paul Yoo, OD, VP, Clinical & Regulatory Affairs

Chris Kissling, VP, Business Development & Account Management
Luca M. Sergio, CEO & Owner
Michael Smolinsky, PhD, Chief Content Officer

Onkar Sawant, PhD, Director of Research

Evolve Therapeutics
Donald Fishbein, President

EW Healthcare Partners
William Andrews, Partner

ExoVision Biosciences
Brad Webb, PhD, CEO

ExSight Ventures
James Murray, Partner
Michael Nissen, MD, Partner
Firas Rahhal, MD, Partner

Eye and Lasik Center
Pierre Alfred, MD

Eye News TV
Tom Pace, Producer

Rafal Farjo, PhD, CEO

Jay Cormier, CEO

Eyedetec Medical
Barry Linder, MD, President & CEO

EyeGate Pharma
Stephen From, CEO

Francisco Leonardo Amparo Pulido, MD, Clinical and Scientific Advisor

Storm Charbonneau, Commercial Operations, Manager
Tsontcho Ianchulev, MD, CEO & CMO
Michael Rowe, VP, Marketing
Beth Scott, OD, Medical Affairs

EyePoint Pharmaceuticals
Scott Jones, Chief Commercial Officer
Nancy Lurker, President & CEO
Sanjay Malieckal, PharmD, Senior Director, Marketing
Dario Paggiarino, MD, Chief Medical Officer
Keyur Patel, PharmD, VP, Medical Affairs
Michelle Poole, Executive Director, Marketing
Stasi Savacool, Senior Product Manager
Joe Smith, Executive Director, Business Development

EyeQ Research
Michael Lachman, President

Eyevance Pharmaceuticals
Wes Brazell, CFO
Mark Jasek, PhD, Chief Scientific officer
Brent Jones, VP, Sales
Christian Murray, Director, Marketing
Jerry St. Peter, CEO
Jason Werner, COO

Ronald Buggage, MD, Chief Medical Officer
Patricia Zilliox, PhD, CEO & President

Eye-Yon Medical
Nahum Ferera, CEO & Co-Founder


Eva Rorer, Medical Officer

FisherBroyles LLP
John Shimmick, JD, MS, Partner

Fishkind-Bakewell-Maltzman-Hunter & Associates EyeCare & Surgery Center
Brock Bakewell, MD, Director

Flying L Partners
Jeevan Gore, COO
William Link, PhD, Managing Director

ForSight Labs
K. Angela Macfarlane, Managing Partner

Forsight Vision6
Ayman Naseri, MD, President & CMO

Foulkes Vision Institute
Richard Foulkes, MD, Director

Foundation Fighting Blindness
Todd Durham, VP, Clinical & Outcomes Research
Rusty Kelley, VP, Investments & Alliances
Jason Menzo, Chief Operating Officer
Benjamin Yerxa, CEO

Foundation for Ophthalmology Development, Poznan, Poland
Andrzej Grzybowski, MD, PhD, Head

F-Prime Capital
Lucille Conroy, MD

Frank Bucci
Frank Bucci, Jr., MD, Medical Director

Fritch Eye Care
Charles Fritch, MD, Owner & Physician


Galimedix Therapeutics
Hermann Russ, MD, PhD, CSO
Peter Serra, VP Finance

Ganot Capital
Guy Katsav, Managing Director, Healthcare Investments

Gebauer Medizintechnik GmbH
Steffen Gebauer, Managing Director
Peter Klopotek, PhD, CTO
Peter Litman, CEC

Amitabha Bhakta, PhD, MSL
Christopher Brittain, VP, Global Head of Ophthalmology Product Development
Hao Chen, PhD, Senior Clinical Scientist
Mitchell D'Rozario, PhD, MSL
Erin Henry, PhD, US Marketing
Phillip Lai, MD, Senior Medical Director
Siyang Liu, MBA, MPH, Senior Manager
Rose Mastracci, PhD, Senior Manager
George Mavro, Digital Health Platforms
Amit Mehta, Director
Ben Novak, Senior Marketing Manager
Shriang Ranade, PhD, Technical Development
Temmy Sasore, PhD, Medical Science Liaison
Eric Strauss, MD, Lead Group Medical Director

Julio Benedicto, VP, Marketing
Laure Blouin, Clinical Analyst
Thomas Gidoin, CFO
Staphanie Leouzon, Business Advisor
Isabelle Scarabin, Business, Development Director
Magali Taiel, VP, Clinical Development

Glaucoma Research Foundation
Thomas Brunner, President & CEO

Glaucoma Specialists of San Francisco
Iryna Falkenstein, MD

Glauconix Biosciences
Kim Southern, Chief Operating Officer
Karen Torrejon O'brien, CSO

Glaukos Corporation
Jane Rady, SVP, Corporate Strategy & Business Development

Global Research Management
Lucy Bataneant, MD, Clinical Research Director
Sherif El-Harazi, MD, MPH, President

GoCheck Kids
Kevon Saber, CEO

Gray Communications
Michele Gray, Principal

Graybug Vision
Fred Guerard, CEO
Rajendra Mohabir, PhD, VP, Product Development & Alliance Management
Daniel Salain, COO
Charles Semba, MD, Chief Medical Officer
Lynda Valerie Smith, VP, Global Clinical Development Operations
Karl Trass, VP, Global Regulatory Affairs

Guggenheim Partners
Dana Flanders, Analyst

Guggenheim Securities
Cameron Taylor, Managing Director

Gyroscope Therapeutics
Susan Hill, PhD, Chief Business Officer
Forbes Huang, VP, Business Development


H.C. Wainwright & Co.
Yi Chen, PhD, Managing Director

Haffey & Co.
Lewis Baloian, Partner
Bernie Haffey, President

HanAll Biopharma
Hyeakyung Ahn, Head, BioResearch Center
Joo Hyun Chae, Program Manager
Youngju Kim, Director, HPI
Minjae Shin, Alliance Advisor

Harvard Ophthalmology
Sunil Chauhan, PhD, Associate Professor

Horizon Therapeutics
Dominic Borie, MD, VP, External R&D

Horowitz Group
Jason Tester, CFO

Rodrigo Garcia, MD

Courtney Smith, Director, Business Development & Licensing
Carla Vozone, VP, Pharmaceutical Development & Licensing

Rubal Bedi, Global Head, Vice President
Akiteru Furukawa, General Manager
Rakhi Jain, PhD, VP, Global Research & Development
James Kaiser, Director, VC Group

HTM Polska
Stephane Le Bourhis, President

Hyogo Prefectural Amagasaki General Medical Center
Hideyasu Oh, MD, PhD


iCandy Consulting
Candace Simerson, FASOA, COE, President & CEO

Icare Finland Oy
Rami Haulisto, R&D Manager

ICON Eye Care
James Fox, MD

Iconic Therapeutics
William Greene, MD, CEO

Linda Danielson, COO & EVP
Sophie De Gronckel, Project Manager

Illinois Institute, Technology
Jennifer Kang-Mieler, PhD, Associate Professor, Biomedical Engineering

Illinois Retina Associates
John Pollack, MD, Partner

ILSUNG Pharmaceuticals
Minyoung Jung, PhD, Director

Indiana University School of Medicine
Louis Cantor, MD, Chair & Professor
Thomas Ciulla, MD, Volunteer Clinical Professor
Alon Harris, MS, PhD, FARVO, Professor, Ophthalmology

InFocus Capital Partners
Robert Rothman, MD, Managing Partner
Ron Weiss, MD, Managing Partner

InFocus Clinical
Brad Doerschuk, President, CEO

Inova Fairfax
Michael Ross, MD

Institut de la Màcula, and Barcelona Macula Foundation
Jordi Monés, MD, PhD, Director

Interface Biologics
Wendy Naimark, PhD, VP, R&D
Ian Parrag, Senior Engineer, Manager
Tom Reeves, President & CEO

International Healthcare Media
Christopher Ciraulo, CEO & President

Invus Opportunities
Ron Bache, Operating Partner

IOPtima Ltd.
Ronen Castro, CEO

Amy Del Medico, Ophthalmology CoE Co-Chair
Kitty Gordon, MD, Medical Director

Iridex Corporation
Bassem Bouhabib, VP, International Sales

Iris Pharma
Yann Quentric, MSc, President

Ammad Khan, CEO

Istanbul Bilim University
Murat Oncel, MD, Professor, Ophthalmology

iSTAR Medical
Zubair Hussain, PhD, VP Regulatory & Clinical Affairs
Stefan Uhrlandt, PhD, VP Research & Development
Michel Vanbrabant, CEO

iVeena Delivery Systems
Bala Ambati, President & Founder
Michael Burr, VP, Product Development
Gerald Simmons, CEO

Iveric bio
David Carroll, Chief Financial Officer
Adrienne Graves, PhD, Independent Director
David Guyer, MD, Executive Chairman
Vishal Kapoor, Chief Business Officer
Kourous Rezaei, MD, Chief Medical Officer
Glenn Sblendorio, CEO
Keith Westby, Chief Operating Officer


Mitchell Jackson, MD, Founder & CEO

Pete Adamson, VP & Global Head Retinal Disease Area Stronghold Ophthalmology
Eddy Anglade, MD, Vice President
Cynthia Aronson, Senior Director, External Innovation
Thomas Gustafson, VOP-CVM Innovation
Sarah Brennan, VP, Business Development & Licensing, CVM
Bruno Costa Gabriel, Commercial Strategy Leader CVM & WWDA
Penny Fleck, VP, CVM Portfolio & Retinal Development
James List, Global Therapeutic Area Head, Cardiovascular & Metabolism

Paul Bresge, CEO

JGP Asset Management
Suy Anne Martins, MD, PhD, Investor

JMP Securities
Donald Ellis, Analyst
David Schechner, Managing Director

Johns Hopkins Technology Ventures
Amy House, Associate Director, Corporate Partnerships

Johns Hopkins University School of Medicine, Wilmer Eye Institute
Peter McDonnell, MD, William Holland Wilmer Professor & Director

Johnson & Johnson Vision, Surgical
Caroline Blackie, OD, PhD, Medical Director, Ocular Surface Disease
Leonard Borrmann, Head, External Innovation
Christian Cuzick, CFO, Surgical
Allie Holmes, Director, Comms & Public Affairs
Thomas Frinzi, Worldwide President, Surgical Vision
Ken Kadziauskas, Director, Upstream Marketing, Surgical
Biren Mehta, VP, Business Development, CSS Franchise and Vision
Ashley McEvoy, EVP, Worldwide Chairman, Medical
Rich Minevich, Senior Manager, Business Development
Shlomi Nachman, CGC, CSS Franchise and Vision
Nancy Ondovik, PharmD, Senior Director, Business Development
Callie Parker, Strategic Support Director
Andrew Pilon, Senior Director New Ventures
MK Raheja, PhD, MBA, Head of R&D, Ophthalmic Platform
Tom Ruggia, VP, Customer Experience, Surgical
Brian Schwam, MD, Senior Director, External Innovation & Medical Science Strategy
Nick Tarantino, OD, Head, Global Clinical Sciences
Prabhu Velusami, MD, New Ventures & Transactions Lead, Vision
Nivine Woods, Director, Global Marketing, Surgical
Troy Wu, MD, Senior Director, Business Development
Jonathan Talamo, MD, Chief Medical Officer & Worldwide VP, Medical & Clinical Affairs


Kala Pharmaceuticals
Todd Bazemore, COO
Kim Brazzell, MD, PhD, Chief Medical Officer
Hongming Chen, Chief Scientific Officer
Mark Iwicki, Chairman & CEO
Niranjan Kameswaran, VP, Strategy
Kate Kline, VP, Marketing
Sarah Watson, Senior Director, Market Access Strategy
James Yanek, Director, Professional Relations
Steven Zhang, MD, PhD, VP, Medical Affairs

Kaleidoscope Innovation
Benjamin Ko, Engineering Manager
Matthew Suits, Manager - Business Development

Kedalion Therapeutics
Mark Blumenkranz, MD, CEO, Chairman & Co-Founder
Casey Dougan, VP, Corporate Development
Peter Noymer, PhD, CEO

Chris Japp, Managing Director

Keio University School of Medicine
Kazuo Tsubota, MD, PhD, FARVO, MBA, Professor and Department Chair

Arjun Arora, Principal
Kal Rao, Associate
Roger Sawhney, MD, Director, Healthcare

Kleiner Perkins
Brook Byers, Partner

Knight Therapeutics
Winston Karges, Manager, Business Development

Kodiak Sciences
Jason Ehrlich, MD, PhD, Chief Medical Officer & Chief Development Officer

Konan Medical USA
Charles Stewart, OD, CEO

Kx Advisors
BoB Serrano, SVP


LaserVue Eye Center
Jay Bansal, MD, Medical Director

Kenneth Mandell, MD, PhD, CEO

Nick Curtis, President & CEO

Michael Landreville, COO
David Lawrence, Chief Business Officer
Ramgopal Rao, CEO

Robin Sears, CEO

Leo Lens Technology
Kenny Key, COO & General Counsel

Saiid Davari, VP, Investigator Relations
Chad Ice, CEO
Michael Schiewe, Director, Business & Site Development

Lifecore Biomedical
Kipling Thacker, PhD, Chief Scientific Officer & VP

Lightstone Ventures
Anne Rubin, Entrepreneur-in-Residence

Lilly Asia Ventures
John Hu, Advisor
Liang Lin, Partner
Sean Zhang, Investment Manager

Link Consulting
Marsha Link, PhD, Principal

Lion VisionGift
Corrina Patzer, Chief Strategy Officer

London Vision Clinic - Retina
Paulo Eduardo Stanga, MD, Consultant Ophthalmologist & Lead Vitreoretinal Surgeon

Long Beach Eye Care Associates
Donald Schwartz, MD, Physician

Lubrizol Advanced Materials
Carey Boyum, Key Account Manager

Duane Morrison, VP, Sales
Tracy Puckett, VP Marketing
Art Taylor, Board Member
Clark Tedford, PhD, President & CEO

Nicolas Gobeill, Head Business Development

Lyfe Capital
Keting Chu, MD, PhD, Venture Partner

Lynthera Corporation
Caesar Luo, MD, CTO


Mark Packer MD Consulting
Corinne Packer, Treasurer
Mark Packer, MD, President

Market Scope
William Freeman, Vice President
Kristen Ingenito, Vice President

Massachusetts Eye & Ear
Bonnie Brodowski, Director, Corporate & International Development
Joseph Ciolino, MD, Associate Professor, Ophthalmology
Reza Dana, MD, Claes H. Dohlman Professor, Ophthalmology
Joan Miller, MD, Chief & Chair, Ophthalmology

Matossian Eye Associates
Cynthia Matossian, MD, Founder & Medical Director

Maze Therapeutics
Nina Oberbeck, PhD, Scientist II

McDermott & Bull Executive Search
Jake Vander Zanden, Technology & Life Science Practice Leader

Media MICE
Robert Anderson, Director of Strategies and Media
Travis Plage, Finance Director
Matt Young, CEO & Publisher

Thomas Seitz, MBA, VP, Sales

Giovanni Mariggi, Partner
Nick Williams, Associate

Vanitha Sekar, PhD, Executive Director of BD&L

Katey Mulfinger, VP of Operations and Marketing

Terry Bowlin, PhD, CEO
Richard Gauthier, Chief Business Officer

Chris Pulling, CEO

Minnesota Eye Consultants
Richard Lindstrom, MD, Founder & Attending Surgeon

Mitotech S.A.
Anton Petrov, COO

Difei Yang, Analyst

Mizuho Securities USA
Alexandre Bouilloux, Research Associate, SMID Biotech

Mojo Vision
Drew Perkins, CEO
Ashley Tuan, OD, PhD, VP, Medical Devices

Moose Jaw Ophthalmology
Matthew Regan, MD

MT Coroneo Pty Ltd
Minas Coroneo, MD, Professor

MVM Partners
Akhilesh Pathipati, MD, Principal

Kevin Pratt, VP, Sales


Nan Fung Life Sciences
Peter Bisgaard, Managing Director
Jennifer Lee, Senior Associate
Davis Yang, Senior Associate

Nanovision Biosciences
Scott Thorogood, Chairman & CEO

Tak Cheung, MD, Principal

Serge Belanger, Analyst

Neovista Eye Institute
Andre Romano, MD, Medical Director

Karl Schweitzer, CEO

Jonathan Javitt, MD, MPH, CEO

Neurotech Pharmaceuticals
Rich Small, CEO

Raul Trillo, Chief Commercial Officer

New England Eye Center
Caroline Baumal, MD
Jay Duker, MD, Director

New Sight Pharma
Gustavo Gaqrcia, PhD, CEO

New York Eye and Ear Infirmary of Mount Sinai
James Tsai, MD, MBA, President

Tera Roy, VP Business Development

Kamakshi Sharma, Senior Analyst

Nicox Ophthalmics
Jose Boyer, PhD, VP, Clinical Development
Krisi Lopez, Clinical Project Manager

Nitto Medic
Kunihiko Shiina, Executive Advisor

North Valley Eye Medical Group
Steven Rauchman, MD

Northwest Eye Clinical
John (Chip) Berestka, MD, Medical Director

Notal Vision
Grace Chang, MD, PhD, Chief Medical Officer
Kester Nahen, PhD, Chief Commercial Officer
Susan Orr, OD, CEO

Novaliq GmbH
Schlueter Oliver, Managing Director, CFO
Christian Roesky, PhD, Managing Director & CEO

Joe Boyd, Executive Director, Market Development
Lisa Bridell, Associate Director
Begona Carreno, PhD, Global Head of BD&L Ophthalmology
Arthur Chen, Lead Medical Director
Arthur Ciociola, PhD, VP, Global Franchise Head Regulatory Affairs Ophthalmology
Ahmed Deraz, Executive Director & Head of Eye Care Marketing
Dhaval Desai, VP & Medical Unit Head, US Ophthalmology
Casey Dietrich, Director, Strategic Accounts
Peter DiNardi, Northwest Market Development
Greg DiPasquale, VP & Head of Sales
Heather Floyd, Worldwide Director, New Products Ophthalmology
Steve Gill, Though Leader Liaison
Usha Gutti, Manager
Stephanie Hicks, WW Director New Products Head
Doug Hubatsch, Global Brand Medical Director
Dimitrios Lizos, PhD, BD&L Head Search & Evaluation Ophtha
Arianne Llana, TLL
Jan Michell, Thought Leader Liaison
Patrick Mooney, VP & Head, Ophthalmology Franchise
Karen Netherton, Global Patient Access Head, Ophthamology
Ashish Patel, Marketing Director
LeaAnne Patel, Associate Director
Rex Penza, Thought Leader Liaison
Constantina Poga, Director
Robyn Ramsdill, Thought Leader Liaison
Marisel Salzger, New Products
Dirk Sauer, PhD, Global Development Unit Head, Ophthalmology Unit
Josh Smith, Director
Paul Smith, VP, Business Unit Head - Eye Care
Gregg Stanhope, AD, Thought Leader Liaison, National OPH
Jehan Tamboowalla, VP, Head of New Products, Ophthalmology
Stephane Wolf, WorldWide Brand Director

Ran Yam, CEO

Knut Sturmhoefel, Head BD&L Ophthalmology
Nikolaos Tripodis, Worldwide Franchise Head Ophtha

Noveome Biotherapeutics
David Steed, MD, EVP, Clinical Affairs & Chief Medical Officer
Patrick Welch, MBA, Director

Novo Ventures
Ken Harrison, Principal

NVision Eye Centers
Sheri Rowen, MD, Medical Director


Theresa Kramer, MD, MBA, Ophthalmic Pathologist

Kelly Beck, VP, Investor Relations & Administration
Shankar Musunuri, PhD,Chairman & CEO
Sanjay Subramanian, Chief Financial Officer

Ocular Instruments
Phil Erickson, President
Ray Graham, Director Engineering & Research

Ocular Surgery News & Healio
John Hova, Section Editor, Blogger
David Mullin, Senior Editorial Director
Patricia Nale, Executive Editor
Peter Slack, President
Scott Wright, Sales Director

Ocular Therapeutix
Scott Corning, SVP, Commercial Operations
Michael Goldstein, MD, Chief Medical Officer
Bindu Manne, Director, Market Development
Antony Mattessich, President & CEO
Donald Notman, CFO
Christopher White, SVP, Corporate Development

Riad Sherif, MD, CEO

Kevin Quinn, VP Sales and Business Development
Kathryn Taylor, MPH, Managing Director & Founder

Oculos Clinical Research
Benjamin Burton, President & CEO
Ronil Patel, Business Development

Keith Ignotz, MBA, President & CEO

Ocunexus Therapeutics
Brian Levy, OD, MSc, CEO
David Pool, CFO

Joseph Messina, PhD, COO

Ocuphire Pharma
Mina Sooch, MBA, CEO

Kurt Riegger, President

Ocutrx Vision Technologies
Michael Freeman, CEO & Chief Technology Officer
Linda Lam, MD, MBA, Chief Scientific & Strategy Officer
Victoria McArtor, Chief Communications Officer

Winfried Teiwes, CEO & Managing Director

OHSU Casey Eye Institute
Brandon Lujan, MD, Associate Professor

Eric Daniels, MD, COO
Quinton Oswald, Director

OIS Press
Steve Lenier, Managing Editor

Brian Strem, CEO

Omar Consulting Group
Cheryl Rowe-Rendleman, PhD, CEO & Managing Consultant

Omeros Corporation
Tim Duffy, VP, Business Development
Rahim Hirji, Director, Marketing

ONL Therapeutics
David Esposito, CEO

OnPoint Vision
Kevin Cady, CEO

Mark Dlugoss, Senior Contributing Editor

Ophthalmology Times
Erin Schlussel, Publisher
Sheryl Stevenson, Group Editorial Director

Oppenheimer & Company
Esther Rajavelu, Executive Director

Chris Redhead, PhD, CEO

Opthea Limited
Megan Baldwin, Managing Director & CEO

Ryan Bouchard, VP, Medical Devices
Cody Bullen, Business Development
Justin Cooper, Business Development
Norberto Diaz, Business Development
Susan Francia, Business Development
Sanjeev Ganatra, Director, Business Development
James Golando, Chief Operating Officer
Jeanne Hecht, Chief Strategy Officer
Lisa Jennings, Senior Director, Global Alliance Business Development
Richie Kahn, Director, Business Development
Keith Lane, Senior Director
Josh Moriarty, Executive Director, Business Development
Michihito Onishi, Director, Business Development
George Ousler, VP, Dry Eye
Aron Shapiro, SVP & Chief Commercial Officer
Stewart Sylvestor, Business Development
Sally Tucker, PhD, Head of EU Operations
Andy Whitlock, PhD, VP of Pre-Clinical Research & Development

Orasis Pharmaceuticals
Elad Kedar, CEO

Anat Naschitz, Managing Director

Outlook Therapeutics
Terry Dagnon, COO
Jeff Evanson, Chief Commercial Officer
Jennifer Kissner, PhD, SVP, Clinical Development

Patrik De Haes, MD, CEO
Wouter Piepers, Global Head Investor Relations & Corporate Communications
Claude Sander, Chief Legal Officer, Head of Market Access, Secr. of the Board

Oyster Point Pharma
Michael Ackermann, PhD, Chairman
Loni da Silva, VP, Regulatory Affairs
George Donato, VP, CMC
Dawn Koffler, VP, Marketing
Daniel Lochner, CFO
Mark Murray, Board Member
Jeffrey Nau, PhD, President & CEO
John Snisarenko, Chief Commercial Officer
Kristen Striffler, Associate Director, Clinical Development


P&T Magazine
Peter Sonnenreich, Editor

Pacific Eye Institute
Jesse Dovich, MD, Ophthalmologist
Mila Heersing, MD, Ophthalmologist

Palo Alto Investors
John Doux, Investor

Panoptes Pharma
Franz Obermayr, CEO

PDL BioPharma
Roz Sweeney, PhD, Senior Director, Business Development

Jennifer Ford, Senior Managing Editor, Retinal Physician & Glaucoma Physician Magazines

Perfect Lens
Steven Smathers, President

Pharmaceutical Product Evaluation
Pierre Paul Elena, PhD, Chief Scientific Officer

PharmaQuest Associates
Lisa Grillone, PhD, President

Tom Kelly, CEO
Jeffrey Lenk, Chief Technology Officer
Darrell White, MD, Board Advisor

Photoswitch Therapeutics
John Flannery, PhD, Professor

Jenny Song, Preclin Oph Lead

Piper Jaffray
Joseph Catanzaro, Senior Biotech Analyst
J.P. Peltier, Managing Director, Global Head, Healthcare Investment Banking

Pivotal bioVenture Partners
Robert Hopfner, Managing Partner
Ash Khanna, PhD, Venture Partner
Heather Preston, MD, Managing Partner

Lloyd Diamond, CEO

Suresh Pemmaraju, Manager

Russell Tait, CEO
Vanessa Waddell, Head, Commercial Operations & Business Development

Powered Research
Chris Brasfield, Director, Business Development
David Culp, PhD, Director of Research
Justin Prater, Study Director

Leif Erickson, Senior Director, Business Development
Dave Frakes, MD, VP & Regional Medical Officer
Jaime Garvey, Director Clinical Team Management
Rodney Hill, Director of Project Management, Ophthalmology Pillar
Tracey Roberts, Senior Director, Global Project Management

Jochen Kumm, Founder
Darius Moshfeghi, MD, Founder

PRA Health Sciences
Maria Yankova, MD, MBA, MPH, Medical Director Ophthalmology

Gerrit Naus, CEO

Precise Bio
Lior Shav, Business Development

Pres-By Vision
Barak Azmon, MD, Director

Presbyopia Therapies
Jim McCollum, Co-Founder & Board Member

Prisma Eye Institute
Alan Leahey, MD, Ophthalmologist

Promedica International
Khan Lau, OD, MBA, Director, Clinical Operations
Shannon Stoddard, President & CEO

Proqr Therapeutics
Aniz Girach, MD, Chief Medical Officer

Dominik Escher, Partner


Quark Venture
Neena Kadaba, PhD, Director


RA Capital Management
Zach Scheiner, Principal
Laura Stoppel, Associate

Radiance Therapeutics
Harry George, President & CFO
Abigail Mackrill, Director, BD & Outreach
Laurence Marsteller, MD, CEO

Raymond James
Andrew Gitkin
David Kaufman, Associate
Jake Kreuz, Associate
Kyle Madan, Director

Mike Judy, President & CEO

Regenera Pharma
Alon Netser, CFO
Jordan Rubinson, CEO

Regeneron Pharmaceuticals
Fouad Amer, Executive Director Medical Affairs Ophthalmology
Muna Bitar, PharmD, Associate Director, Ophthalmology, Medical Affairs
Jingtai Cao, MD, PhD, Director, Ophthalmology
Vincenzo Cavaliere, Medical Specialist
Kevin Clark, Executive Director Marketing
Stephen Marshall, Manager Strategic Analysis
Steven Miller, Business Development
Carmelo Romano, PhD, Executive Director, Ophthalmology
Steven Simmons, Associate Director Medical Affairs Ophthalmology Sciences
Samir Tari, Senior Director Medical Affairs
Chad Webre, Associate Director Strategic Accounts
Jonathan Weyne, MD, Senior Director, Clinical Development
David Willy, Sales Director - Diabetic Eye

Stacey Curtiss, PharmD, Head of Medical Affairs
Darin Curtiss, Clinical Devlopment
Anya Derbij, Senior Director
Ken Mills, CEO
Christina Ohnsman, MD, Senior Clinical Development Lead
Stephen Pakola, MD, Chief Medical Officer
Samir Patel, MD, Clinical Scientist, Medical Affairs
Monica Roy, Program Development Lead- Ophthalmology
Reka Shinkle, VP of Commercial & Portfolio Management
John Zhong, PhD, Vice President

Nicholas Adams, VP Business Development & Alliance Management
Rick Beckman, Chief Medical Officer
Olav Hellebo, CEO

Retina Associates of Cleveland
Lawrence Singerman, MD, FACS, Founder

Retina Consultants of Houston
Charles Wykoff, MD, Director of Research

Retina Research Center
Brian Berger, MD, President

Houman Hemmati, MD, PhD, Clinical Development

Retinal Consultants of Arizona/Retinal Research Institute
Pravin Dugel, MD, Managing Partner

Retinal Consultants of AZ
Derek Kunimoto, MD, JD

Retina-Vitreous Associates Medical Group
David Boyer, MD, Senior Partner

Review of Ophthalmology/Review of Optometry
Michele Barrett, Manager
Walter Bethke, Editor in Chief

Rebecca Hussain, President

Ribomic USA
Yusuf Ali, PhD, CEO

Richel Liu, CEO

Rock Springs Capital
Maulik Shah, Analyst

Ross Eye Institute
Alex Chop, MD, PhD, Comprehensive Ophthalmologist

Christopher Stanley, Chief Business Officer, CFO

Ilya Goldshleger, VP, Engineering
Ron Kurtz, MD, President & CEO
Eric Weinberg, Chief Commercial Officer


Samsung Bioepis
Bryan Chu Young Kim, Vice President
Christopher Hansung Ko, CEO
Steven Suk Hwon Lee, Senior Manager

Nir Israeli, CEO

Abu Abraham, VP, Vitreous & Retina TA Strategy
Robert Bauer, Director, Business Development EMEA
Dustin Cavida, Medical Science Liaison
Almira Chabi, MD, Vice President
Victor Chan, Director, US Surgical Device Commercial Marketing
Frank Chen, Corporate Ventures
Tsuyoshi Chiwata, Associate Director, US Business Development and Venture Management
Francisco Garcia, MBA, US Marketing
Lisa Her, Corporate Communications
Takeo Hirose, Vice President
Jean Kim, PhD, Venture Capital Analyst
Rocky Kuroki, Manager, US Business Development
Sri Mudumba, VP, Retina Franchise Lead & Pharmaceutical Development
Masatsugu Nakamura, PhD, Deputy Head, Biomedical Strategy and Research
Omar Sadruddin, MD, Global Medical Director
Peter Sallstig, MD, SVP, Head, Product Development, Global R&D
Naveed Shams, MD, PhD, Head, Global R&D, Chief Scientific Officer, Senior Corporate Officer
Ed Zastawny, Senior MSL

SB Strat Dev Consultants
Sharon Bakalash, MD, PhD, Founder & CEO

Scheie Eye Institute at UPenn
Joan O'Brien, MD, Chairman

Schepens Eye Research Institute
Hidenaga Kobashi, MD, Clinical Fellow

SciFluor Life Sciences
D. Scott Edwards, PhD, VP & General Manager

Senju Pharmaceutical
Yutaka Inoue, Manager

Sentiss Pharmaceuticals
Jena Thompson, Director, Business Development & Operations
Satish Srinivasan, President - North America

Shire (A Takeda Company)
Robert Dempsey, Head, Global Ophthalmology Franchise
Scott Hunter, Global Marketing Lead - Ophthalmics
Sushanta Mallick, PhD, MBA, VP, GDL
Beth Marsh, Global Product Strategy Lead

Shore Research & Development
John Hall, President

Fabrizio Chines, Chairman & CEO

SightGlass Vision
Tom Chalberg, PhD, Founder & CEO
Michael Fertik, Founder & Chief Strategy Officer
Joseph Rappon, Chief Medical Officer

Paul LaBarre, MS, SVP of Access and Innovation

SightLine Partners
Buzz Benson, Managing Director

Silicon Valley Bank
Jonathan Norris, Managing Director

SilkTech Biopharmaceuticals
Brian Lawrence, PhD, CEO

Singapore Eye Research Institute
Danny Belkin, PhD, MBA, Director, Technology Development & Commercialization
Tarun Kumar Maheshwari, Senior Manager
Denise Teoh, Senior Manager

John Carter, COO

Savas Komban, CEO

SMI Holding
Eberhard Schmidt, Managing Director

Soho BioConsulting
Jinzhong Zhang, PhD, Principal

Spark Therapeutics
Dustin Shilling, New Product Planning, Senior Associate

Square 1
Lauren Gyoerkoe, Founder & Strategist

STAAR Surgical
Joanne Egamino, PhD, Global Head, Clinical Operations
David Friess, OD, VP, North America Clinical Strategy & Professional Affairs
Jon Hayashida, OD, VP, Global Clinical & Medical Affairs

David Owen, PhD, VP, Research

Stealth BioTherapeutics
Brian Hotchkiss, Head, Business Development & New Product Planning

Stein Eye Institute/UCLA
Eliot Dow, MD, PhD
Steven Schwartz, MD, Ahmanson Professor in Ophthalmology

Stephenson Eye Associates
Dee Stephenson, MD, FACS

Nick Rubino, Analyst

Strategic Intelligence
Babak Nemati, PhD, President & CEO

Stuart Therapeutics
Bob Baratta, MD, Chairman & CMO
Eric Schlumpf, President & CEO

Summit Rock Strategy Consulting
Sandra Ruggles, PhD, President

Sun Ophthalmics
Ryan Bleeks, National Sales Director
Ryan Brown, Associate Director, Professional Relations
Pat Fetaya, Senior Director, Business Development & Strategy
Mark Hagler, SVP, Head Ophthalmic
Abayomi Ogundele, Senior Director, Ophthalmology Medical Head, Medical Affairs
Drew Parks, Director, Professional Relations

Surface Pharmaceuticals
Kamran Hosseini, MD, PhD, CEO

Surgical Eyecare PA
Alan Brown, MD, Practice Manager

Patrick Johnson, PhD, Chief Business Officer
Kenneth Widder, MD, CEO

Syneos Health
Laszlo Bekesi, MD, VP, Clinical Development Ophthalmology
Kathleen Fanning, Senior Director, Operations
Nicholas Spittal, SVP, Clinical Development
Stacey Stein, Director, Business Development, Medical Devices & Diagnostics


Taejoon Pharmaceutical
Joon Youb Lee, CEO

Take One Productions
Aaron Keller, Videographer & Editor
Andrew Leos, Senior Director Video Production
Russell Welch, Editor

Tarsius Pharma
Daphne Langford, CEO

Tarsus Pharmaceuticals
Bobby Azamian, MD, PhD, CEO
Mark Holdbrook, VP, Clinical Affairs

Tauber Eye Center
Joseph Tauber, MD

Philip Gioia, Commercial Operations
Rick Heinick, Chairman
Kevin Hershfield, CEO
Srini Venkatesh, CSO

Texere Publishing
Neil Hanley, Publisher

TFG Education
Brad Fundingsland, President
Rebecca Winter, Global Business Development

Marcia Swank, Director of Project Management, Ophthalmology

TGP Communications
Teresa Panas, Principal

The Cooper Companies
Kelly Tran, Senior Corporate Development Analyst

The Eye Associates
Cathleen McCabe, MD, Medical Director

The Macula Center
Michael Tolentino, MD, Partner

The Magnum Group
Randy Mcdonald, Business Development Consultant

The New York Eye & Ear Infirmary
Robert Ritch, Surgeon Director & Chief, Glaucoma Services

The Ophthalmologist
Sam Blacklock, Associate Publisher
Phoebe Harkin, Deputy Editor

Thea Laboratories
Jean Chibret, President
Colin Francou, Business Development Manager
Celine Olmiere, Scientific Manager

Thea Open Innovation
Anne De Brugerolle, Business Development Manager

Thea Pharmaceuticals
Susan Benton, General Manager & Head, U.S.

Third Rock Ventures
Jeff Finer, PhD, Venture Partner
George Xu, PhD, Venture Associate

Tilak Healthcare
Vinona Bhatia, MD, MPH, Chief Medical Officer

TissueTech (Bio-Tissue)
Timothy Gilbert, Senior Manager, Professional Relations & Education
Andrew Jones, Associate VP, Marketing
Shrikant Rahalkar, VP, Marketing

Tokyo Medical and Dental University
Kyoko Ohno-Matsui, MD, PhD, Professor & Chair, Department of Ophthalmology & Visual Science

Erica Smith, PhD, VP, Business Development

Ajay Duggal, Chief Medical Officer
Martyn Foster, Chief Scientist
Anuj Madhok, Chief Business Officer
Steve Webber, PhD, Chief Scientific Officer

Tracery Ophthalmics
Chris Bott, Senior Adviser
Shelley Boyd, MD, President & CEO

Trefoil Therapeutics
David Eveleth, CEO
Ben McGraw, PharmD, Executive Chairman
Schalon Newton, DM, Chief Business Officer

Trial Runners
Brandon Beaudoin, Director, Clinical Development
Patrick Healy, President, Chief Development Officer
Cameron Marshall, Business Development Director
Kelsey McDonald, Clinical Development Ambassador

Truhlsen Eye Institute
Ronald Krueger, MD, MSE, McGaw Memorial Professor & Chairman, Director

Tsubota Laboratory
Yoichi Horiba, Manager, Sales Team

Tyson Eye
Farrell Tyson, MD, Medical Director


Forest Flodin, Director, Business Development

UCI Health Gavin Herbert Eye Institute
Sumit Garg, MD, Vice Chair of Clinical Ophthalmology, Medical Director & Associate Professor

UCSF School of Medicine
Daniel Schwartz, MD

Unither Pharmaceuticals
Josh Myers, Business Development Manager

Universidad de Monterrey
Mauel Garza, MD

University Hospital Bern
Marion Munk, MD, PhD,

University Hospital Zurich
Sandrine Zweifel, MD, Head, Medical Retina & Imaging Service, Department of Ophthalmology

University of Arizona College of Medicine
Brennan Boyd

University of California Irvine
Mitul Mehta, MD

University of California, San Diego
Robert Weinreg, MD, Chair & Distinguished Professor, Ophthalmology

University of California, San Francisco
Thuy Doan, MD, PhD, Assistant Professor

University of Colorado School of Medicine
Cristos Ifantides, MD, MBA, Director, Ophthalmic Global Outreach
Malik Kahook, MD, Slater Family Chair in Ophthalmology

University of Illinois at Chicago
William Mieler, MD, Cless Family Professor, Ophthalmology

University of Michigan
David Zacks, MD, PhD, Physician

University of Pennsylvania
Alexander Brucker, MD, Professor of Ophthalmology

University of Southern California
Mark Humayun, MD, PhD, Professor, Ophthalmology

University of Texas Southwest
Martin Mullen, MD, Resident

University of Wisconsin-Madison
Paul Kaufman, MD, Professor Emeritus of Ophthalmology

UPike College of Optometry/Kentucky Eye Institute
Paul Karpecki, OD, Associate Professor

Alexander Anetakis, MD, MBA, Physician

Lu Chen, MD, PhD, Professor


Valley Retina Institute
Victor Gonzalez, MD, CEO

Valley Retina PC
Shihwa Chang, MD, CEO

Vance Thompson Vision
Vance Thompson, MD, Director, Refractive Surgery

Vance Thompson Vision/Equinox/Expert Opinion
John Berdahl, MD, Surgeon & Partner

Vantage Eye Care
Mark Blecher, MD, Managing Partner, Philadelphia Eye Division

Eileen McCullough, SVP, Operations and Corporate Strategy
Cyrus Mozayeni, MD, CEO

Veloce BioPharma
Samuel Barone, MD, Chief Medical Officer

Harry Barber, MBBS, Portfolio Manager

Vensana Capital
Kirk Nielsen, Managing Partner
Cynthia Yee, Principal

Verana Health
Bill Abbott, Business Development Executive - Clinical Trails
Donald Butler, VP, Commercial & Clinical Trials
Karim Damji, VP, Head of Product
Hylton Kalvaria, VP, Strategic Partnerships
Miki Kapoor, CEO
Chet Kumar, VP, Life Science & Commercial

Versant Ventures
Charles Warden, Managing Director

Vertical Pharmaceuticals
Nicholas Fee, Director, Commercial Development & Business Development
David Jacobs, MD, VP, Clinical Development and Medical Affairs
Michelle Manzo, MPH, Medical Science Liaison
Brian Markison, CEO
JD Schaub, Chief Operating Officer

Vestrum Health
Nadeem Ahmad, COO
Tom Brogan, CEO

ViewPoint Therapeutics
Brian Connolly, Senior Director of Operations
Ed Hurwitz, Board Member
Robert Kim, PhD, CMO
Leah Makley, PhD, CEO

Virginia Eye Consultants
John Sheppard, MD, President
Elizabeth Yeu, MD, Partner

Visant Medical
Vartan Ghazarossian, PhD, President & CEO
Shravanthi Reddy, PhD, COO

Yonatan Manor, PhD, CEO

Vision CRC
Arthur Back, PhD, Managing Director

Vision Ophthalmic Development International
Rhett Schiffman, MD, MS, MHSA, President & CEO

Visionary Eye Institute
Ehsan Sadri, MD, FACS, Founder & CEO

Visionary Venture Fund
Garrett Hamontree, Principle
Jeffry Weinhuff, Managing Partner

Visionary Ventures
Daniel Gil, PhD, Venture Partner

Steve Denelsky, Board Member
Blake Michaels, President & CEO
Wolfgang Tolle, Board Chairman

VISUfarma BV
Keren Leshem, VP, Corporate Development
Thomas Van Haarlem, MD, CEO

Vivo Capital
Chen Yu, Managing Partner

VRM Consultants of New York
K. Bailey Freund, Clinical Professor


Warby Parker
Kathleen Maloney, OD, Senior Medical and Clinical Affairs Manager

Waring Vision Institute
George Waring IV, MD, Medical Director

Warrenville EyeCare & LASIK
Lisa Nijm, MD, JD, Founder & Medical Director

WCCT Global
Yosuke Izumi, Director, Business Development
Oriana Lewallen, Associate Director, Project Management

Andrew Goldberg, MD Physician

Wills Eye Hospital
Christopher Rapuano, MD, Chief, Cornea Service

Wisconsin Alumni Research Foundation
Greg Keenan, Accelerator Manager
Michael Partsch, Chief Venture Officer


Yale University School of Medicine
Lucian Del Priore, MD, PhD, Professor & Chair, Department of Ophthalmology and Visual Science

Yelroc Consulting
Andy Corley, Principal

YOLIA Health
ALberto Osio, CEO


Ziemer Ophthalmic Systems AG
Nikolaus Kaiser, Business Development

Patrick Sauvageau, OD, MSc, CEO

Zuhal Butuner, CMO


James Taylor, CEO


Benedikt Warum, Product Manager